跳至主要内容
临床试验/NCT01782105
NCT01782105已完成不适用

Intervention en Changement Des Habitudes de Vie Par l'Activité Physique et un Support Nutritionnel Durant la Grossesse en Estrie

Université de Sherbrooke2 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2011年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
16
试验地点
2
主要终点
Weight change during pregnancy

研究概览

简要总结

The purpose of this study are:

  • Assess the impact of an intervention to the adoption of healthy lifestyles among pregnant women at high risk of gestational diabetes mellitus on:

  • weight gain in pregnancy

  • the levels of maternal and fetal adipokines and

  • glycemic control maternal and fetal.

  • Determine whether the adoption of healthy lifestyles in pregnancy is associated with epigenetic changes that influence the levels of adipokines and glucose regulation during pregnancy and in newborns.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • be aged ≥ 18 years,
  • have a pre-pregnancy BMI ≥ 25 kg/m2,
  • be at risk of developing a gestational diabetes mellitus (a history of gestational diabetes mellitus or glucose 1 hour post-50g > 7.1 mmol/L.

排除标准

  • Pre-pregnancy diabetes detected in the first trimester (A1c > 6.5%, fasting glucose > 7.0 mmol/L, random blood glucose> 11.1 mmol/L, glucose > 10.3 mmol/L 1 hour post-50g)
  • twin pregnancy
  • taking medications that can affect blood sugar or weight,
  • practice ≥ 150 minutes of physical activity per week
  • against formal-indication for physical activity.

结局指标

主要结局

Weight change during pregnancy

时间窗: Weeks 12, 24, 36 of gestation

次要结局

  • Levels of maternal and fetal adipokines(Weeks 12, 24 of gestation and at delivery (in cord blood))
  • Maternal and fetal glycemic control(Weeks 12, 24 of gestation and at delivery)
  • Determine whether the adoption of healthy lifestyle in pregnancy is associated with epigenetic changes that influence the levels of adipokines and glucose regulation during pregnancy and in newborns.(Weeks 12, 24 of gestation and at delivery (cord blood))
  • Optimize the intervention before measuring its impact on the prevention of gestational diabetes mellitus on a larger scale.(throughout the study)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Marie-France Hivert

MD, MSc

Université de Sherbrooke

研究点 (2)

Loading locations...

相似试验